Sleep Device Testing

November 3, 2022 updated by: Duke University

Clinical Testing of a Novel Device to Promote Sleep Continuity in Infants

Infants often have sleep challenges. Most of these challenges in otherwise healthy children and due to behavioral insomnia. The goal for infants is to become independent sleepers by learning the process of self-soothing. This study hopes to determine if technology based on sensors is able to help teach self-soothing to infants.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 months to 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age between 4-12 months.
  2. Meets clinical criteria for behavioral insomnia of childhood, sleep association subtype, as defined by the International Classification of Sleep Disorders Manual.

Exclusion Criteria:

  1. Diagnosed comorbid health problem that may disrupt sleep.
  2. History of birth prior to 37 weeks gestational age.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sleep Device intervention
Infants will utilize the sleep device during sleep for 20 days
Infants will sleep on a novel device with built-in sensor technology that tracks sleep patterns and provides output based on historical sleep data.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of total discrete crying episodes as measured by parent sleep diary
Time Frame: 1 month
Parents will fill out sleep diaries to track changes over the duration of the study
1 month
Number of discrete crying episodes between time asleep and time awake as measured by parent sleep diary
Time Frame: 1 month
Parents will fill out sleep diaries to track changes over the duration of the study
1 month
Number of minutes of crying at night (total) as measured by sleep device report
Time Frame: 1 month
Sleep device tracks crying through a microphone.
1 month
Number of minutes of crying between time asleep and time awake as measured by sleep device report
Time Frame: 1 month
Sleep device tracks crying through a microphone.
1 month
Number of minutes of quiet wakefulness as measured by sleep device report
Time Frame: 1 month
Sleep device tracks crying and wakeful through a microphone and accelerometer.
1 month
Number of minutes of quiet wakefulness between time asleep and time awake as measured by sleep device report
Time Frame: 1 month
Sleep device tracks crying and wakeful through a microphone and accelerometer.
1 month
Number of minutes of wakefulness as measured by parent sleep diary
Time Frame: 1 month
Parents will fill out sleep diaries to track changes over the duration of the study
1 month
Number of minutes of wakefulness between time asleep and time awake as measured by parent sleep diary
Time Frame: 1 month
Parents will fill out sleep diaries to track changes over the duration of the study
1 month
Total length of time asleep as measured by parent sleep diary
Time Frame: 1 month
Parents will fill out sleep diaries to track changes over the duration of the study
1 month
Total length of time in bed as measured by parent sleep diary
Time Frame: 1 month
Parents will fill out sleep diaries to track changes over the duration of the study
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Sujay Kansagra, MD, Duke

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2021

Primary Completion (Actual)

July 31, 2022

Study Completion (Actual)

July 31, 2022

Study Registration Dates

First Submitted

October 4, 2021

First Submitted That Met QC Criteria

October 8, 2021

First Posted (Actual)

October 14, 2021

Study Record Updates

Last Update Posted (Actual)

November 4, 2022

Last Update Submitted That Met QC Criteria

November 3, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00103800

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insomnia Chronic

Clinical Trials on Sleep sensor technology

3
Subscribe